New antiviral targets common viruses - including COVID and Zika
Hebrew University's ViroBlock announces preliminary success of anti-viral drug platform.
Hebrew University's ViroBlock announces preliminary success of anti-viral drug platform.
Rishon LeZion municipality sprays around patient's home in attempt to stop spread of virus.